FIRST SCHEDULE
Sections 2 and 58A
[Act 30 of 2012 wef 01/05/2013]
Controlled Drugs
Part I
CLASS A DRUGS
1.  The following substances and products:
(1)Acetorphine
(2)Acetylmethadol
(3)Allylprodine
(4)Alphacetylmethadol
(5)Alphameprodine
(6)Alphamethadol
(7)Alphaprodine
(8)2-Amino-1-(2,5-dimethoxy-4-methyl)phenylpropane
(9)Amphetamine
(10)Anileridine
(11)Benzethidine
(12)Benzylmorphine (3-benzylmorphine)
(13)1-Benzylpiperazine (also known as BZP)
(14)Betacetylmethadol
(15)Betameprodine
(16)Betamethadol
(17)Betaprodine
(18)Bezitramide
(19)4-Bromo-2,5-dimethoxy-α-methylphenethylamine (also known as Brolamfetamine or DOB)
(20)4-Bromo-2,5-dimethoxyphenethylamine (also known as 2C-B)
(21)Bufotenine
(22)Buprenorphine
(23)Cannabinol
(24)Cannabinol derivatives
(25)Cannabis and cannabis resin
(26)Cathinone
(27)Clonitazene
(28)Coca leaf
(29)Cocaine
(30)Codoxime
(31)4-Cyano-2-dimethylamino-4,4-diphenylbutane
(32)4-Cyano-1-methyl-4-phenyl-piperidine
(33)Desomorphine
(34)Dextromoramide
(35)Diamorphine
(36)Diampromide
(37)Diethylthiambutene
(38)N,N-Diethyltryptamine
(39)Difenoxin
(40)Dihydroetorphine
(41)Dihydromorphine
(42)Dimenoxadole
(43)Dimepheptanol
(44)2,5-Dimethoxy-4,α-dimethyl-phenethylamine
(45)2,5-Dimethoxy-α-methylphenethylamine
(46)N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine (also known as MDMA)
(47)3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
(48)Dimethylthiambutene
(49)N,N-Dimethyltryptamine
(50)Dioxaphetyl butyrate
(51)Diphenoxylate
(52)Dipipanone
(53)Drotebanol
(54)Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine
(55)4-Ethyl-2,5-dimethoxy-α-methylphenethylamine
(56)N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine (also known as MDEA)
(57)Ethylmethylthiambutene
(58)Eticyclidine
(59)Etonitazene
(60)Etorphine
(61)Etoxeridine
(62)Etryptamine
(63)Furethidine
(64)Gamma hydroxybutyric acid
(65)Hydrocodone
(66)Hydromorphinol
(67)Hydromorphone
(68)1-Hydroxy-3-pentyl-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6-H-dibenzo[b,d]pyran
(69)Hydroxypethidine
(70)Isomethadone
(71)Ketamine
(72)Ketobemidone
(73)Levomethorphan
(74)Levomoramide
(75)Levophenacylmorphan
(76)Levorphanol
(77)Lysergamide
(78)Lysergide and other N-alkyl derivatives of lysergamide
(79)Mescaline
(80)Metazocine
(81)Methadone
(82)Methadyl acetate
(83)Methamphetamine (also known as Methylamphetamine)
(84)5-Methoxy-N,N-diisopropyltryptamine
(85)3-Methoxy-α-methyl-4,5-(methylenedioxy)phenethylamine
(86)p-Methoxy-α-methylphenethylamine
(87)N-Methyl-α-ethyl-3,4-(methylenedioxy)phenethylamine (also known as MBDB)
(88)N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine
(89)α-Methyl-3,4-(methylenedioxy)phenethylamine (also known as Tenamfetamine or MDA)
(90)2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid
(91)1-Methyl-4-phenylpiperidine-4-carboxylic acid
(92)4-Methylaminorex
(93)Methyldesorphine
(94)Methyldihydromorphine (6-Methyldihydromorphine)
(95)4-Methylthioamphetamine
(96)3-Methylthiofentanyl
(97)Metopon
(98)Monoacetylmorphine
(99)Morpheridine
(100)Morphine
(101)Morphine methobromide, morphine N-oxide and other pentavalent nitrogen morphine derivatives
(102)Myrophine
(103)Nicomorphine (3,6-dinicotinoyl-morphine)
(104)Noracymethadol
(105)Norbuprenorphine
(106)Norketamine and its dehydro derivatives
(107)Norlevorphanol
(108)Normethadone
(109)Normorphine
(110)Norpipanone
(111)Opium
(112)Oxycodone
(113)Oxymorphone
(114)Parahexyl (3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran)
(115)Pethidine
(116)Phenadoxone
(117)Phenampromide
(118)Phenazocine
(119)Phenomorphan
(120)Phenoperidine
(121)4-Phenylpiperidine-4-carboxylic acid ethyl ester
(122)Piminodine
(123)Piritramide
(124)Poppy-straw and concentrate of poppy-straw
(125)Proheptazine
(126)Properidine (1-Methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester)
(127)Psilocin
(128)Psilocybine
(129)Racemethorphan
(130)Racemoramide
(131)Racemorphan
(132)Remifentanil
(133)Rolicyclidine
(133A)Tapentadol
[S 572/2014 wef 01/09/2014]
(134)Tenocyclidine
(135)Thebacon
(136)Thebaine
(137)Tilidine
(138)1-(3-Trifluoromethylphenyl)piperazine (also known as TFMPP)
(139)Trimeperidine
(140)3,4,5-Trimethoxy-α-methylphenethylamine
2.  Any stereoisomeric form of a substance for the time being specified in paragraph 1, not being dextromethorphan or dextrorphan.
3.  Any ester or ether of a substance for the time being specified in paragraph 1 or 2, not being a substance for the time being specified in Part II.
4.  Any salt of a substance for the time being specified in any of paragraphs 1, 2 and 3.
5.  Any preparation or other products containing a substance or product for the time being specified in any of paragraphs 1 to 4.
6.  Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1, 2 and 3 of Part II.
7.  Fentanyl and any compounds structurally derived from N-(1-Methyl-4-piperidyl)-N-phenyl formamide by substitution of any of the hydrogen atoms, including the following; and any salt of any substance falling within this item:
(1)Alfentanil
(2)Alpha-methyl fentanyl
(3)Alpha-methyl fentanyl acetanilide
(4)Alpha-methylthiofentanyl
(5)Benzyl fentanyl
(6)Beta-hydroxy fentanyl
(7)Beta-hydroxy-3-methyl fentanyl
(8)Carfentanil
(9)Lofentanil
(10)3-Methyl fentanyl
(11)Para-fluorofentanyl
(12)Sufentanil
(13)Thiofentanyl
8.  Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)(1-Butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-073)
(2)(4-Chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-398)
(3)[1-(4-Chloropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as 4-Chloro-AM-2201)
(4)(4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-210)
(5)[1-(5-Fluoropent-1-yl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone (also known as MAM-2201)
(6)[1-(5-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as AM-2201)
(7)[1-(4-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as 4-Fluoro-AM-2201)
(8)[1-(5-Fluoropent-1-yl)-6-nitro-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as AM-1235)
(9)[1-(Heptan-2-yl)-2-methyl-1H-indol-3-yl](naphthalen-1-yl)methanone (also known as JWH-011)
(10)(1-Heptyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-020)
(11)(1-Hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-019)
(12)(4-Methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-081)
(13)(2-Methyl-1-propyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-015)
(14)(4-Methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-122)
(15){1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone (also known as AM-1220)
(16){1-[2-(Morpholin-4-yl)ethyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone (also known as JWH-200)
(17)Naphthalen-1-yl[1-(pent-4-en-1-yl)-1H-indol-3-yl]methanone (also known as JWH-022)
(18)Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone (also known as JWH-018)
(19)Naphthalen-1-yl(1-propyl-1H-indol-3-yl)methanone (also known as JWH-072)
9.  Any compound containing a 3-(1-naphthylmethyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)3-[(4-Methylnaphthalen-1-yl)methyl]-1-pentyl-1H-indole (also known as JWH-184)
(2)3-(Naphthalen-1-ylmethyl)-1-pentyl-1H-indole (also known as JWH-175)
10.  Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)[5-(2-Chlorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-369)
(2)[5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-307)
(3)[5-(3-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-368)
(4)(1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-147)
(5)(1-Hexyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (also known as JWH-031)
(6)[5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone (also known as JWH-370)
(7)Naphthalen-1-yl[5-(naphthalen-1-yl)-1-pentyl-1H-pyrrol-3-yl]methanone (also known as JWH-309)
(8)Naphthalen-1-yl(1-pentyl-5-phenyl-1H-pyrrol-3-yl)methanone (also known as JWH-145)
(9)Naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone (also known as JWH-030)
11.  Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)E-1-[1-(1-Naphthalenylmethylene)-1H-inden-3-yl]pentane (also known as JWH-176)
12.  Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)2-(2-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-203)
(2)1-[1-(2-Cyclohexylethyl)-1H-indol-3-yl]-2-(2-methoxyphenyl)ethanone (also known as RCS-8)
(3)2-(2-Methoxyphenyl)-1-{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}ethanone (also known as cannabipiperidiethanone)
(4)2-(2-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-250)
(5)2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-302)
(6)2-(4-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-201)
(7)2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (also known as JWH-251)
13.  Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not substituted in the cyclohexyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)2-[5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol (also known as CP55,940)
(2)2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol (also known as CP47,497)
14.  Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)[1-(5-Fluoropentyl)-1H-indol-3-yl](2-iodophenyl)methanone (also known as AM-694)
(2)(2-Iodo-5-nitrophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-1241)
(3)(2-Iodophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-2233)
(4)(2-Iodophenyl)(1-pentyl-1H-indol-3-yl)methanone (also known as AM-679)
(5)(4-Methoxyphenyl){2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone (also known as pravadoline)
(6)(4-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone (also known as RCS-4)
15.  Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, and any derivatives of the above compounds containing hydroxy and/or carboxylic acid groups, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent, including any salt or stereoisomeric form of the above compounds or derivatives, and any preparation or product containing the above compounds or derivatives, for example:
(1)Adamantan-1-yl{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone (also known as AM-1248)
(2)Adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone (also known as AB-001)
16.  Any compound, other than bupropion, that is structurally derived from 2-amino-1-phenylpropan-1-one by modification in any of the following ways:
(a)substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(b)substitution at the 3-position with an alkyl substituent;
(c)substitution at the nitrogen atom with alkyl or dialkyl, benzyl or methoxybenzyl groups, or by inclusion of the nitrogen atom in a cyclic structure,
including any salt or stereoisomeric form of the above compounds, and any preparation or product containing the above compounds, for example:
(1)1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-propanone (also known as bk-MDDMA)
[S 254/2015 wef 01/05/2015]
(2)1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one (also known as ethylone)
(3)1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one (also known as butylone)
(4)1-(1,3-Benzodioxol-5-yl)-2-(methylamino)pentan-1-one (also known as pentylone)
(5)1-(1,3-Benzodioxol-5-yl)-2-(methylamino)propan-1-one (also known as methylone or 3,4-methylenedioxy-N-methylcathinone)
(6)1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one (also known as MDPBP)
(7)1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as 3,4-methylenedioxypyrovalerone or MDPV)
(8)1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one (also known as MDPPP)
(8A)1-(4-Bromophenyl)-2-(methylamino)propan-1-one (also known as 4-Bromomethcathinone or Brephedrone or 4-BMC)
[S 254/2015 wef 01/05/2015]
(8B)1-(4-Chlorophenyl)-2-(methylamino)propan-1-one (also known as 4-Chloromethcathinone or Clephedrone or 4-CMC)
[S 254/2015 wef 01/05/2015]
(9)2-(Dimethylamino)-1-phenylpropan-1-one (also known as metamfepramone or dimethylcathinone)
(10)1-(3,4-Dimethylphenyl)-2-(methylamino)propan-1-one (also known as 3,4-Dimethylmethcathinone or 3,4-DMMC)
[S 254/2015 wef 01/05/2015]
(10A)2-(Ethylamino)-1-(4-fluorophenyl)propan-1-one (also known as 4-Fluoroethcathinone or 4-FEC)
[S 254/2015 wef 01/05/2015]
(11)2-(Ethylamino)-1-(4-methylphenyl)propan-1-one (also known as 4-Methylethcathinone or 4-MEC)
[S 254/2015 wef 01/05/2015]
(12)2-(Ethylamino)-1-phenylbutan-1-one (also known as N-ethylbuphedrone)
(13)2-(Ethylamino)-1-phenylpentan-1-one (also known as α-Ethylaminopentiophenone)
(14)2-(Ethylamino)-1-phenylpropan-1-one (also known as ethcathinone)
(14A)1-(4-Ethylphenyl)-2-(methylamino)propan-1-one (also known as 4-Ethylmethcathinone or 4-EMC)
[S 254/2015 wef 01/05/2015]
(15)1-(4-Fluorophenyl)-2-(methylamino)propan-1-one (also known as 4-Fluoromethcathinone or Flephedrone or 4-FMC)
[S 254/2015 wef 01/05/2015]
(15A)1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as 4-Fluoro-α-PVP)
[S 254/2015 wef 01/05/2015]
(16)1-(4-Methoxyphenyl)-2-(methylamino)propan-1-one (also known as 4-Methoxymethcathinone or Methedrone or bk-PMMA or PMMC)
[S 254/2015 wef 01/05/2015]
(17)1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)propan-1-one (also known as MOPPP)
(18)2-(Methylamino)-1-phenylbutan-1-one (also known as buphedrone)
(19)2-(Methylamino)-1-phenylpentan-1-one (also known as pentedrone)
(20)2-(Methylamino)-1-phenylpropan-1-one (also known as methcathinone)
(21)1-(4-Methylphenyl)-2-(methylamino)propan-1-one (also known as 4-Methylmethcathinone or Mephedrone or 4-MMC)
[S 254/2015 wef 01/05/2015]
(22)1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)butan-1-one (also known as MPBP)
(23)1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as pyrovalerone)
(24)1-Phenyl-2-(pyrrolidin-1-yl)butan-1-one (also known as α-PBP)
(25)1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one (also known as α-PVP)
(26)1-Phenyl-2-(pyrrolidin-1-yl)propan-1-one (also known as α-PPP)
17.  Any compound that is structurally derived from 2-aminopropan-1-one by substitution at the 1-position with any monocyclic, or fused-polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways:
(a)substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
(b)substitution at the 3-position with an alkyl substituent; or
(c)substitution at the 2-amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure,
including any salt or stereoisomeric form of the above compounds, and any preparation or product containing the above compounds, for example:
(1)1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (also known as naphyrone or naphthylpyrovalerone)
(2)2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one (also known as α-Pyrrolidinopentiothiophenone or α-PVT)
18.  The following compounds, including any salt or stereoisomeric form of such compounds, and any preparation or product containing such compounds:
(1)N-(1-Adamantyl)-5-fluoropentyl-1H-indazole-3-carboxamide (also known as 5-Fluoro-APINACA or 5F-AKB48) and its fluoro positional isomers in the pentyl group
[S 254/2015 wef 01/05/2015]
(1A)N-(1-Adamantyl)-5-fluoropentyl-1H-indole-3-carboxamide (also known as 5-Fluoro-APICA or STS-135) and its fluoro positional isomers in the pentyl group
[S 254/2015 wef 01/05/2015]
(1B)N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (also known as APINACA)
[S 254/2015 wef 01/05/2015]
(2)N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide (also known as APICA)
(2A)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as AB-FUBINACA) and its fluoro positional isomers in the phenyl ring
[S 254/2015 wef 01/05/2015]
(2B)4-(2-Aminopropyl)benzofuran (also known as 4-APB)
[S 254/2015 wef 01/05/2015]
(3)5-(2-Aminopropyl)benzofuran (also known as 5-APB)
(4)6-(2-Aminopropyl)benzofuran (also known as 6-APB or BenzoFury)
(4A)7-(2-Aminopropyl)benzofuran (also known as 7-APB)
[S 254/2015 wef 01/05/2015]
(4B)4-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 4-APDB)
[S 254/2015 wef 01/05/2015]
(5)5-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 5-APDB)
(6)6-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 6-APDB)
(6A)7-(2-Aminopropyl)-2,3-dihydrobenzofuran (also known as 7-APDB)
[S 254/2015 wef 01/05/2015]
(6B)2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25B-NBOMe)
[S 254/2015 wef 01/05/2015]
(7)17-Carboxy-16,17-dihydromitragynine
(8)16-Carboxymitragynine
(8A)2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25C-NBOMe)
[S 254/2015 wef 01/05/2015]
(9)17-O-Desmethyl-16,17-dihydromitragynine
(10)9-O-Desmethylmitragynine
(10A)3,4-Dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (also known as AH-7921) and its dichloro positional isomers in the phenyl ring
[S 254/2015 wef 01/05/2015]
(11)2,3-Dihydro-1H-inden-2-amine (also known as 2-Aminoindane)
(12)6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (also known as 5,6-(methylenedioxy)-2-aminoindane or MDAI)
(13)2,3-Dihydro-5-iodo-1H-inden-2-amine (also known as 5-Iodo-2-aminoindane or 5-IAI)
(14)[2,3-Dihydro-5-methyl-3-(morpholin-4-ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl](naphthalen-1-yl)methanone
(15){4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-en-2-yl}methanol
(15A)2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25H-NBOMe)
[S 254/2015 wef 01/05/2015]
(16)6,6-Dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1,9-diol
(17)N,N-Dimethyl-1-phenylpropan-2-amine (also known as N,N-dimethylamphetamine)
(18)Diphenyl(pyrrolidin-2-yl)methanol (also known as diphenylprolinol)
(19)2-Diphenylmethylpiperidine (also known as desoxypipradrol)
(20)[1-(5-Fluoropent-1-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (also known as XLR-11 or 5-Fluoro-UR-144) and its fluoro positional isomers in the pentyl group
[S 254/2015 wef 01/05/2015]
(21)1-(4-Fluorophenyl)piperazine (also known as 4-Fluorophenylpiperazine or 4-FPP) and its fluoro positional isomers in the phenyl ring
[S 254/2015 wef 01/05/2015]
(22)1-(4-Fluorophenyl)propan-2-amine (also known as 4-Fluoroamphetamine or 4-FA) and its fluoro positional isomers in the phenyl ring
[S 254/2015 wef 01/05/2015]
(23)1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6,6a,7,8,10,10a-hexahydro-9H-benzo[c]chromen-9-one
(24)[9-Hydroxy-6-methyl-3-(5-phenylpentan-2-yl)oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate
(25)3-Hydroxy-2-[3-methyl-6-(2-propenyl)-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone
(26)9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
(27)7-Hydroxymitragynine
(27A)2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25I-NBOMe)
[S 254/2015 wef 01/05/2015]
(28)2-(3-Methoxyphenyl)-2-(N-ethylamino)cyclohexanone (also known as methoxetamine)
(29)N-Methyl-1-(4-fluorophenyl)propan-2-amine (also known as 4-Fluoromethamphetamine or 4-FMA) and its fluoro positional isomers in the phenyl ring
[S 254/2015 wef 01/05/2015]
(30)N-Methyl-1-(4-methoxyphenyl)propan-2-amine (also known as 4-Methoxymethamphetamine or para-Methoxymethamphetamine or PMMA) and its methoxy positional isomers in the phenyl ring
[S 254/2015 wef 01/05/2015]
(31)N-Methyl-1-(4-methylphenyl)propan-2-amine (also known as 4-Methylmethamphetamine or 4-MMA) and its methyl positional isomers in the phenyl ring
[S 254/2015 wef 01/05/2015]
(32)(N-Methyl-4-phenylpiperidin-4-yl)propanoate (also known as desmethylprodine)
(33)N-Methyl-1-(thiophen-2-yl)propan-2-amine (also known as methiopropamine)
(34)1-(4-Methylbenzo-1,3-dioxol-6-yl)propan-2-amine (also known as 5-methyl-MDA or 5-methyl-3,4-methylenedioxyamphetamine)
(35)Mitragynine
(36)Naphthalen-1-yl(4-pentyloxynaphthalen-1-yl)methanone (also known as CB-13)
(37)5-[3-(1-Naphthoyl)-1H-indol-1-yl]pentanenitrile (also known as AM-2232)
(38)(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (also known as UR-144)
(38A)Quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate (also known as BB-22 or QUCHIC)
[S 254/2015 wef 01/05/2015]
(38B)Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (also known as 5-Fluoro-PB-22 or 5-Fluoro-QUPIC) and its fluoro positional isomers in the pentyl group
[S 254/2015 wef 01/05/2015]
(38C)Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (also known as PB-22 or QUPIC)
[S 254/2015 wef 01/05/2015]
(39)Salvinorin A
[S 323/2014 wef 01/05/2014]
Part II
Class B Drugs
1.  The following substances and products:
 Acetyldihydrocodeine.
Nicodicodine.
 Codeine.
Norcodeine.
 Dextropropoxyphene.
Phencyclidine.
 Dihydrocodeine.
Phenmetrazine.
 Ethylmorphine (3-ethylmorphine).
Pholcodine.
 Fenetylline.
Propiram.
 Methylphenidate.
Zipeprol.
 Nicocodine.
 
2.  Any stereoisomeric form of a substance for the time being specified in paragraph 1.
3.  Any salt of a substance for the time being specified in paragraph 1 or 2.
4.  Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3, not being a preparation falling within paragraph 6 of Part I.
Part III
Class C Drugs
1.  The following substances:
 Benzphetamine.
Methaqualone.
 Chlorphentermine.
Nimetazepam.
 Flunitrazepam.
Phendimetrazine.
 Mecloqualone.
Pipradrol.
 Mephentermine.
Secobarbital.
 
Triazolam.
2.  Any stereoisomeric form of a substance for the time being specified in paragraph 1.
3.  Any salt of a substance for the time being specified in paragraph 1 or 2.
4.  Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3.
Part IV
Meaning of Certain Terms Used in This Schedule
For the purposes of this Schedule —
“cannabinol derivatives” means the following substances, namely tetrahydro derivatives of cannabinol and their carboxylic acid derivatives, and 3-alkyl homologues of cannabinol or its tetrahydro derivatives;
“coca leaf” means the leaf of any plant of the genus Erythroxylon from whose leaves cocaine can be extracted either directly or by chemical transformation;
“concentrate of poppy-straw” means the material produced when poppy-straw has entered into a process for the concentration of its alkaloids;
“opium poppy” means any plant from which morphine may be produced;
“preparation” means a mixture, solid or liquid, containing a controlled drug;
“poppy-straw” means all parts, except the seeds, of the opium poppy, after mowing.
[40/93; 2/2006; S 88/79; S 238/83; S 229/84; S 272/84; S 31/86; S 50/90; S 564/91; S 66/92; S 262/95; S 223/96; S 469/97; S 391/99; S 232/2000; S 493/2001; S 30/2004; S 507/2005; S 491/2006]